Abstract:To report the results of 'responsive' deep brain stimulation (DBS) for Tourette syndrome (TS) in a National Institutes of Health funded experimental cohort. The use of 'brain derived physiology' as a method to trigger DBS devices to deliver trains of electrical stimulation is a proposed approach to address the paroxysmal motor and vocal tic symptoms which appear as part of TS. Ten subjects underwent bilateral staged DBS surgery and each was implanted with bilateral centromedian thalamic (CM) region DBS leads and bilateral M1 region cortical strips. A series of identical experiments and data collections were conducted on three groups of consecutively recruited subjects. Group 1 (n = 2) underwent acute responsive DBS using deep and superficial leads. Group 2 (n = 4) underwent chronic responsive DBS using deep and superficial leads. Group 3 (n = 4) underwent responsive DBS using only the deep leads. The primary outcome measure for each of the 8 subjects with chronic responsive DBS was calculated as the pre-operative baseline Yale Global Tic Severity Scale (YGTSS) motor subscore compared to the 6 month embedded responsive DBS setting. A responder for the study was defined as any subject manifesting a ≥ 30 points improvement on the YGTSS motor subscale. The videotaped Modified Rush Tic Rating Scale (MRVTRS) was a secondary outcome. Outcomes were collected at 6 months across three different device states: no stimulation, conventional open-loop stimulation, and embedded responsive stimulation. The experience programming each of the groups and the methods applied for programming were captured. There were 10 medication refractory TS subjects enrolled in the study (5 male and 5 female) and 4/8 (50%) in the chronic responsive eligible cohort met the primary outcome manifesting a reduction of the YGTSS motor scale of ≥ 30% when on responsive DBS settings. Proof of concept for the use of responsive stimulation was observed in all three groups (acute responsive, cortically triggered and deep DBS leads only). The responsive approach was safe and well tolerated. TS power spectral changes associated with tics occurred consistently in the low frequency 2–10 Hz delta-theta-low alpha oscillation range. The study highlighted the variety of programming strategies which were employed to achieve responsive DBS and those used to overcome stimulation induced artifacts. Proof of concept was also established for a single DBS lead triggering bi-hemispheric delivery of therapeutic stimulation. Responsive DBS was applied to treat TS related motor and vocal tics through the application of three different experimental paradigms. The approach was safe and effective in a subset of individuals. The use of different devices in this study was not aimed at making between device comparisons, but rather, the study was adapted to the current state of the art in technology. Overall, four of the chronic responsive eligible subjects met the primary outcome variable for clinical effectiveness. Cortical physiology was used to trigger responsive DBS when therapy was limited by stimulation induced artifacts.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to use "responsive" deep brain stimulation (rDBS) to treat Tourette Syndrome (TS). Specifically, the study aims to verify whether the method of using brain - derived physiological signals to trigger DBS devices to deliver electrical stimulation can effectively reduce the motor and vocal tic symptoms in TS patients. The paper evaluates the safety and effectiveness of this method through three different experimental groups (acute response group, chronic response group, response group using only deep electrodes) and explores the application of different programming strategies in achieving responsive DBS. ### Research Background Tourette Syndrome is a neurological disorder characterized by repeated involuntary movements and vocal tics. Traditional treatment methods include drug therapy and behavioral therapy, but for some refractory patients, these methods may have limited effectiveness. In recent years, deep brain stimulation (DBS) has been proposed as a potential treatment method, especially for those patients who do not respond well to traditional treatments. However, traditional DBS usually adopts continuous stimulation, which may lead to side effects or poor effectiveness. Therefore, researchers have proposed the concept of "responsive" DBS, that is, dynamically adjusting stimulation parameters according to changes in brain activity to more accurately control tic symptoms. ### Research Objectives 1. **Verify Safety**: Evaluate the safety of responsive DBS in TS patients. 2. **Verify Effectiveness**: Evaluate the effectiveness of responsive DBS in reducing motor and vocal tic symptoms in TS patients. 3. **Explore Programming Strategies**: Summarize and analyze different programming strategies for achieving responsive DBS to optimize treatment effects. ### Experimental Design - **Participants**: 10 TS patients who are ineffective to drug treatment. - **Surgical Procedure**: Each patient received DBS electrode implantation in the bilateral centromedian nucleus (CM) area and the primary motor cortex (M1) area. - **Experimental Grouping**: - **Acute Response Group** (n = 2): Use deep and shallow electrodes for acute responsive DBS testing. - **Chronic Response Group** (n = 4): Use deep and shallow electrodes for chronic responsive DBS testing. - **Deep - Electrode - Only Group** (n = 4): Use only deep electrodes for responsive DBS testing. ### Main Results - **Primary Outcome Measure**: Use the motor sub - score of the Yale Global Tic Severity Scale (YGTSS) to evaluate the changes before and after treatment. The criterion defined as a responder is that the YGTSS motor sub - score is reduced by ≥30% under the responsive DBS setting. - **Secondary Outcome Measure**: Use the Modified Rush Videotape Rating Scale (MRVTRS) for video - recorded scoring. ### Results - **Safety**: The responsive DBS method is generally safe, with no serious adverse events. - **Effectiveness**: Among the 8 patients who received chronic responsive DBS, 4 (50%) reached the primary outcome measure. The YGTSS motor sub - score was reduced by an average of 43.5%, the vocal sub - score was reduced by an average of 62.2%, and the overall impression score was increased by an average of 62.5%. - **Programming Strategies**: The study has summarized a variety of programming strategies, including using cortical beta - wave power as a trigger signal, and the technological innovation of using a single DBS electrode for both detection and stimulation simultaneously. ### Conclusion This study shows that responsive DBS is a feasible and effective new method for treating TS, especially in reducing motor and vocal tic symptoms. In addition, the study also provides valuable programming strategies and technical support for future clinical applications.

Responsive deep brain stimulation for the treatment of Tourette syndrome

Effects of Low-Frequency Repetitive Transcranial Magnetic Stimulation of the Bilateral Parietal Cortex in Patients With Tourette Syndrome

Continuous theta burst stimulation for drug-resistant epilepsy

Deep brain stimulation for Tourette syndrome: modulation of the limbic-motor interface network

Efficacy and Safety of Deep Brain Stimulation in Tourette Syndrome: The International Tourette Syndrome Deep Brain Stimulation Public Database and Registry

Deep brain stimulation for Tourette's syndrome

Surgical Concepts and Long-term Outcomes of Thalamic Deep Brain Stimulation in Patients with Severe Tourette Syndrome: A Single-center Experience

Bilateral Globus Pallidus Externus Deep Brain Stimulation for the Treatment of Refractory Tourette Syndrome: An Open Clinical Trial

Thalamo-frontal connectivity patterns in Tourette Syndrome: Insights from combined intracranial DBS and EEG recordings

Thalamic deep brain stimulation for tourette syndrome increases cortical beta activity

Bilateral transcranial magnetic stimulation of the supplementary motor area in children with Tourette syndrome

Stereotactic Surgery for Treating Intractable Tourette Syndrome: A Single-Center Pilot Study

Transcranial Magnetic Stimulation in Tourette Syndrome: A Historical Perspective, Its Current Use and the Influence of Comorbidities in Treatment Response

Spatio-temporal structure of single neuron subthalamic activity identifies DBS target for anesthetized Tourette syndrome patients

An investigation of the effects of α and β-frequency neural entrainment using tACS on phase-aligned TMS-evoked corticospinal excitability

Stereotactic Awake Basal Ganglia Electrophysiological Recording and Stimulation (SABERS): A Novel Staged Procedure for Personalized Targeting of Deep Brain Stimulation in Pediatric Movement and Neuropsychiatric Disorders

Responsive Versus Continuous Deep Brain Stimulation for Speech in Essential Tremor: A Pilot Study

Thalamic stimulation induced changes in effective connectivity

Cingulate dynamics track depression recovery with deep brain stimulation

439 Optimal Targets, Connectivity, and Tissue Integrity for Deep Brain Stimulation in Patients With Disorders of Consciousness

Disruption of neural periodicity predicts clinical response after deep brain stimulation for obsessive-compulsive disorder